Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital & Medical Center, Kansas City, Kansas.
Icahn School of Medicine at Mount Sinai, New York, New York.
J Am Coll Cardiol. 2018 Jan 16;71(2):135-144. doi: 10.1016/j.jacc.2017.10.092.
The impact of left atrial appendage (LAA) exclusion, comparing an epicardial LAA or an endocardial LAA device, on systemic homeostasis remains unknown.
This study compared the effects of epicardial or endocardial LAA devices on the neurohormonal profiles of patients, emphasizing the roles of the renin-angiotensin-aldosterone system and the autonomic nervous system.
This is a prospective, single-center, observational study including 77 patients who underwent LAA closure by an epicardial (n = 38) or endocardial (n = 39) device. Key hormones involved in the adrenergic system (adrenaline, noradrenaline), renin-angiotensin-aldosterone system (aldosterone, renin), metabolic system (adiponectin, free fatty acids, insulin, β-hydroxybutyrate, and free glycerols), and natriuresis (atrial and B-type natriuretic peptides) were assessed immediately before the procedure, immediately after device deployment, at 24 h, and at 3 months follow-up.
In the endocardial LAA device group, when compared with baseline blood adrenaline, noradrenaline and aldosterone were significantly lower at 24 h and 3 months (p < 0.05). There was no significant change in levels post-endocardial LAA device implantation. After epicardial LAA device implantation, there were significant increases in adiponectin and insulin, with decreased free fatty acids at 3 months. There was no significant change in these levels post-endocardial LAA device. N-terminal pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were significantly decreased in the acute phase after epicardial LAA device implantation, which subsequently normalized at 3 months. Post endocardial LAA device implantation, the levels increased immediately and normalized after 24 h. Systemic blood pressure was also significantly lower at all time points after epicardial LAA device implantation, which was not seen post-endocardial LAA device implantation.
There are substantial differences in hemodynamics and neurohormonal effects of LAA exclusion with epicardial and endocardial devices. Further studies are required to elucidate the underlying mechanism of these physiological changes.
左心耳(LAA)排除术,比较心外膜 LAA 或心内膜 LAA 装置,对全身内环境稳定的影响尚不清楚。
本研究比较了心外膜或心内膜 LAA 装置对患者神经激素谱的影响,强调肾素-血管紧张素-醛固酮系统和自主神经系统的作用。
这是一项前瞻性、单中心、观察性研究,包括 77 例接受心外膜(n=38)或心内膜(n=39)装置 LAA 闭合的患者。参与肾上腺素能系统(肾上腺素、去甲肾上腺素)、肾素-血管紧张素-醛固酮系统(醛固酮、肾素)、代谢系统(脂联素、游离脂肪酸、胰岛素、β-羟丁酸和游离甘油)和利钠(心房和 B 型利钠肽)的关键激素在术前、装置部署后即刻、24 小时和 3 个月随访时进行评估。
在心内膜 LAA 装置组中,与基线血肾上腺素相比,去甲肾上腺素和醛固酮在 24 小时和 3 个月时明显降低(p<0.05)。在心内膜 LAA 装置植入后,这些水平没有显著变化。在心外膜 LAA 装置植入后,脂联素和胰岛素显著增加,而游离脂肪酸在 3 个月时减少。在心内膜 LAA 装置植入后,这些水平没有显著变化。在心外膜 LAA 装置植入后,N 端前 A 型利钠肽和 N 端前 B 型利钠肽在急性期明显降低,随后在 3 个月时恢复正常。在心内膜 LAA 装置植入后即刻升高,24 小时后恢复正常。在心外膜 LAA 装置植入后,所有时间点的全身血压均明显降低,而在心内膜 LAA 装置植入后则没有。
心外膜和心内膜装置 LAA 排除术对血液动力学和神经激素的影响有很大差异。需要进一步研究阐明这些生理变化的潜在机制。